SirGenix

Stock code: 6589

EirGenix, Inc.

Notice for 2026 Annual Shareholders' Meeting

(Summary Translation)

1. The 2026 Annual Shareholders' Meeting (the "Meeting") will be convened at 9:30 a.m., May 29, 2026 (Friday) at International Conference Hall, R&D Center, Hsinchu Biomedical Park (2F, No. 8, Sec. 2, Shengyi Rd., Zhubei City, Hsinchu County).

The agenda for the Meeting is as follows:

I. Report Items

(1) 2025 Report the Business Results
(2) 2025 Audit Committee’s Review Report
(3) 2025 Remuneration for the Directors
(4) The 2025 Implementation Report for the Sound Business Plan
(5) Discontinue the Private Security Offering Approved by 2025 Shareholders' Meeting
(6) Amendment to the “Transfer Repurchased Shares to Employees Rules”

II. Proposed Resolutions

(1) Accept 2025 Financial Statements and Business Report
(2) Ratification of the 2025 Deficit Offset Proposal
(3) Adjustment of the Utilization Plan for Capital Injection by the Private Placement in 2021

III. Items for Discussion

(1) Amendment to the “Procedures for Acquisition or Disposal of Assets”
(2) Adoption of the Issuance of Employee Restricted Stock Awards
(3) Approval of Private Placement of Securities
(4) Proposal to Release the Prohibition on Directors or Representatives of Directors from Participation in Competitive Business

IV. Extemporary Motions

1. 2026 1st Employee Restricted Stock Awards: Please refer to the explanatory notes of the proposed resolution on the Meeting Handbook.

2. Private Placement of Securities: Please refer to the explanatory notes of the proposed resolution in the Meeting Handbook.

SirGenix

1. For the shareholders' meeting contents are regulated by Company Act Article 172, please refer to handbook and meeting supplementary information in MOPS system (http://mops.twse.com.tw) with importing Stock code and year.

2. Please find the Notice of Attendance and Proxy form enclosed with this Meeting Notice. If you plan to attend the Meeting in person, please affix your signature or personal seal to the Sign-in Card and submit it for registration on the day of the Meeting. If you wish to appoint a proxy to attend the Meeting, please fill out the name and relevant information of the proxy, affix your signature or personal seal to the Proxy Form, and have the proxy affix his or her signature or personal seal to the Proxy Form. Such Proxy Form shall be delivered to the Company's securities agent at the Register and Transfer Agency division of KGI Securities Corporation, at least five (5) days prior to the Meeting so that a sign-in card can be issued to the proxy.

3. Shareholders, solicitors and authorized agents should bring their identity documents for verification when attending the shareholders' meeting.

4. In compliance with the Article 26-2 of Securities and Exchange Act stating that the notice of the shareholders meeting to be given by an issuer to shareholders who own less than 1,000 shares of nominal stocks may be given in the form of a public announcement; for a regular shareholders meeting, such public announcements shall be served with thirty days prior to notice, the Company will provide only such public announcement to the shareholders who own less than 1,000 shares of nominal stocks.

5. The period during which shareholders may cast electronic votes for the Meeting will be from April 29, 2026 to May 26, 2026. The shareholders may vote online for the Meeting by accessing the "electronic voting platform for shareholders' meeting" page on the website of Taiwan Depository and Clearing Corporation at https://stockservices.tdcc.com.tw, and cast their votes based on the instructions on the website.

6. The institution responsible for tallying and verifying the votes for the Company is the Register and Transfer Agency division of KGI Securities Corporation.

7. If any situation for the case of seeking the Power of Attorney in public, the Company will submit it to S.F.I. (Website: http://free.sfi.org.tw) by April 28, 2026. Please visit the website if requiring any further information.

SirGenix

1. No souvenir will be offered in the Meeting.

Sincerely Yours

The Board of Directors of EirGenix, Inc.

3